glp 1 weight loss medications GLP-1 Drugs from the Gray Market The GLP-1 revolution: What UAB

Recent trials have shown: Up to 20% body weight reduction with weekly GLP-1 agonists (Wilding et al., NEJM) Improvements in HbA1c, fasting glucose, and cardiovascular outcomes (Marso et al., NEJM) This drug class is now widely used for: Obesity (with or without diabetes) Type 2 diabetes PCOS-related insulin resistance Metabolic syndrome Common Side Effects and Patient Concerns Despite their benefits, GLP-1 agonists are not without risks or drawbacks

This peptide, which they named 'exendin-4', not only stimulated insulin secretion in the same way as GLP-1 but also had the advantage that it remained active for more than two hours after subcutaneous injection

Within the tirzepatide treatment arm, the studys most common adverse effect, gastrointestinal disorders, occurred in 46.0% of patients who experienced a cardiorenal end point versus 41.4% of patients who did not

On a 30-unit syringe with half-unit markings, each small line represents 0.5 units

The danger of compounded GLP-1s Cost is a major driver behind some patients choice to use compounded or online versions of GLP-1 medications

Data from VAL was processed using SAS EG 8.2 software and analyzed in Microsoft Excel